GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diadexus Inc (GREY:DDXSQ) » Definitions » Total Payout Ratio

Diadexus (Diadexus) Total Payout Ratio : 0.10 (As of Jun. 10, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Diadexus Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Diadexus's current Total Payout Ratio is 0.10.


Diadexus Total Payout Ratio Historical Data

The historical data trend for Diadexus's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diadexus Total Payout Ratio Chart

Diadexus Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Total Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.06 0.12

Diadexus Quarterly Data
Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16
Total Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 - 0.60 - -

Competitive Comparison of Diadexus's Total Payout Ratio

For the Diagnostics & Research subindustry, Diadexus's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diadexus's Total Payout Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diadexus's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Diadexus's Total Payout Ratio falls into.



Diadexus Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Diadexus's Total Payout Ratio for the fiscal year that ended in Dec. 2015 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0.853 + 0) / -7.166
=0.12

Diadexus's Total Payout Ratio for the quarter that ended in Mar. 2016 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0 + 0) / -1.688
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diadexus Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Diadexus's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Diadexus (Diadexus) Business Description

Traded in Other Exchanges
N/A
Address
349 Oyster Point Boulevard, South San Francisco, CA, USA, 94080-1913
Diadexus Inc is a United States based diagnostics company. It develops and commercializes products that deliver healthcare providers with relevant information to assist in the management of their patients throughout the course of a cardiac disease. Its products include test kits for diagnosis of cardiovascular disease, liver disease, cancer markers, renal disease, diabetes, and electrolytes. Geographically the business presence of the firm is seen in the regions of US, Europe and rest of the world of which US region accounts for the majority of revenue.

Diadexus (Diadexus) Headlines

No Headlines